Abstract:Between 1992 and 1997, 790 blood donors with anti-HCV EIA-2 strongly reagent (relationship between the sample optical density/cut-off > 3) detected at the blood bank serological screening, were evaluated in ambulatory environment. They were all negative for Chagas disease, syphilis, hepatitis B (HBsAg) and AIDS. Blood samples were collected at the first ambulatorial evaluation, for hemogram, biochemical tests and new serological tests for HCV (anti-HCV EIA-2). In blood samples of 226 repeatedly reagent anti-HCV EIA-2 blood donors, supplementary "immunoblot" test for HCV (RIBA-2) was used. In 209 donors, the presence of HCV-RNA was investigated by the PCR test. The abdominal ultrasonography was realized in 366 donors. In 269 patients liver biopsy was performed for the histopathological study. The follow-up of blood donors showed that 95.6% were repeatedly EIA-2 reagent, 94% were symptomless and denied any hepatitis history, with only 2% mentioning previous jaundice. In 47% of this population at least one risk factor has been detected for the HCV transmission, the use of intravenous drugs being the main one (27.8%). Blood transfusion was the second factor for HCV transmission (27.2%). Hepatomegaly was detected in 54% of the cases. Splenomegaly and signs of portal hypertension have seldom been found in the physical examination, indicating a low degree of hepatic compromising in HCV. Abdominal ultrasound showed alterations in 65% of the subjects, being the steatosis the most frequent (50%). In 83. 5% of the donors submitted to the liver biopsy, the histopathological exam showed the presence of chronic hepatitis, usually classified as active (89%) with mild or moderate grade in most of the cases (99.5%). The histopathological exam of the liver was normal in 1.5% of blood donors. The RIBA-2 test and the HCV-RNA investigation by PCR were positive in respectively 91.6 and 75% of the anti-HCV EIA-2 reagent donors. The HCV-RNA research was positive in 82% of the RIBA-2 positive subjects, in 37.5% of the indeterminate RIBA-2 donors and in 9% of the negative RIBA-2 donors. Chronic hepatitis has also been observed in 50% of the histopathological exams of the anti-HCV EIA-2 reagent donors which were indeterminate RIBA-2. Among 18 blood donors with minimal changes histopathological exam 11 (61%) were HCV-RNA positive. Our blood donors anti-HCV reagent generally had clinical, laboratorial and histopathological features observed in patients with chronic HCV hepatitis and a high proportion could be identified in interviews and medical evaluation realized in blood blanks. Generally, these HCV infected donors are identified and discharged only by the serological tests results.

Hepatitis-C Virus-Rna and Antibodies among Blood-Donors in Beijing

The Serologic Study on the Blood Transmission Origin of HIV

Epidemiology of Hepatitis B and C in China

Diverse Genotypes of Hepatitis C Virus in Voluntary Blood Donors in Shanghai, China

Serosurvey for SARS-CoV-2 among Blood Donors in Wuhan,China from September to December 2019

Prevalence of Hepatitis A Viral RNA and Antibodies among Chinese Blood Donors.

Infection with GB Virus C and Hepatitis C Virus in Hemodialysis Patients and Blood Donors in Beijing.

Hepatitis C virus screening reactive among blood donors in mainland China: A systematic review and meta-analysis

Prevalence of Hepatitis C Virus Infection in a Surgical Population of Southeast China: A Large-Scale Multicenter Study.

Prospective Study in 142 Cases of Hepatitis C Virus Infection

The current incidence, prevalence, and residual risk of hepatitis B viral infections among voluntary blood donors in China

Characteristics of HCV Co-Infection among HIV Infected Individuals from an Area with High Risk of Blood-Borne Infections in Central China

Detection of hepatitis B virus DNA among accepted blood donors in Nanjing, China

Hepatitis E virus seroprevalence and molecular study among blood donors in China.

Hepatitis G Virus Infection in Screened Chinese Blood Donors

Prevalence of antibody to hepatitis B surface antigen among qualified blood donors in Nanjing, China

High Frequencies of Hgv and Ttv Infections in Blood Donors in Hangzhou

Prevalence of HBV, HCV and HIV among Village Residents in a Rural Area with Commercial Blood Donors in Shanxi Province

[Investigation of Sub-Clinical Infection of Hepatitis E Virus in Blood Donors].

A clinical, epidemological, laboratorial, histological and ultrasonographical evaluation of anti-HCV EIA-2 positive blood donors

The estimation of prevalence and risk factors of hepatitis B virus infection among blood donors in Chengdu, China